In most studies, around six months of age, males of BPA-treated mothers develop insulin resistance, hyperinsulinemia, hyperleptinemia, decreased adiponectin, dyslipidemia, and decreased β-cell mass. The gene discussed is ADIPOQ; the disease is Hyperinsulinemia.